Journal of Psychopharmacology
"Has shown the highest international standards and should be read by pharmacologists and clinical pharmacologists, as well as by practising psychiatrists, psychologists and doctors involved in the treatment of neurology and psychiatric disorders" - Graham D. Burrows, MD University of Melbourne, Australia
The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology.The journal provides an essential forum for researchers and practising clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects.
Online access:
Journal of Psychopharmacology is available online on SAGE Journals Online at journals.sagepub.com/home/jop
This journal is a member of the Committee on Publication Ethics (COPE).
Submit your manuscript today at https://mc.manuscriptcentral.com/jop.
Essential Reading
The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects.
International Forum
The Journal of Psychopharmacology is truly international in scope and readership. This is reflected by its editorial board which has brought together the very best of clinical and preclinical psychopharmacology from around the world.
Regular Features
Published monthly, the Journal of Psychopharmacology provides readers with an extensive array of regular features, including:
-
Original Research - original scientific papers addressing preclinical and clinical aspects of psychopharmacology
-
Critique - papers on topics of general interest and importance written by experts, commentaries by other authorities and their rejoinders provide the reader with a rounded understanding of the issues involved
-
Perspectives - pithy, thought-provoking, short and focused reviews
-
Letters - facilitating an ongoing dialogue on key issues of psychopharmacology, the letters address issues raised by published articles, or report significant new findings that merit rapid dissemination
-
Sales support materials
-
Exhibit and meeting handouts
-
Direct mail inserts
-
Physician education
-
Seminar literature
-
Educational tools
-
Collections of articles on particular topics
-
Sponsored subscription opportunities
-
Translations
-
Advertising - Including conference listings and related events and launches
-
Discounts - For multiple orders and advance orders in a one year period
The Journal of Psychopharmacology provides an excellent international platform from which to present important clinical and pre-clinical research and an effective way to promote key products to your target audience in supplement or reprint formats.
The journal offers the full range of custom services to meet your individual printing requirements, including:
Journal Supplements - Rapidly produced (under 12 weeks from acceptance to delivery) and competitively priced, should you wish to sponsor an entire Supplement of new and original research material. All supplements are peer reviewed.
Reprints and author offprints - Including customized gloss laminate covers and full printing to requirements, saddle-stitched binding and standard shrink-wrapping at no additional cost. These can be used for:
This journal is a member of the Committee on Publication Ethics (COPE).
| Allan H Young | King’s College London, UK |
| Pierre Blier | University of Ottawa, Canada |
| Pallab Seth | British Association for Psychopharmacology, UK |
| Ian Anderson | Manchester University, UK |
| Simon Bate | GlaxoSmithKline, UK |
| Theodora Duka | Sussex University, UK |
| Barbara J Sahakian | University of Cambridge |
| Clare Stanford | University College London, UK |
| Laith Alexander | King's College London, UK |
| Giovanni Biggio | University of Cagliari, Italy |
| Jeffrey W Dalley | Cambridge University, UK |
| Simon J C Davies | CAMH, University of Toronto, Canada |
| Colin T Dourish | P1vital, UK |
| David P. Finn | National University of Ireland, Galway, Ireland |
| Gary Gilmour | COMPASS Pathways Limited, UK |
| Gabriella Gobbi | McGill University, Canada |
| Guy Goodwin | University of Oxford, UK |
| Roland Griffiths | John Hopkins School of Medicine, Baltimore, USA |
| Catherine Harmer | University of Oxford, UK |
| David J Heal | RenaSci Consultancy Ltd, UK |
| Fredrik Hieronymus | University of Gothenburg, Sweden |
| Sean Hood | University of Western Australia, Perth, Australia |
| Sameer Jauhar | King’s College, London, UK |
| Dr Mario Juruena | King's College London, UK |
| Richard McQuade | Newcastle University, Newcastle, UK |
| Mitul Mehta | King's College London, UK |
| Marcus Munafo | University of Bristol, UK |
| Joanna Neill | University of Manchester, UK |
| Stefano Pallanti | University of Florence, Italy |
| Richard J Porter | University of Otago, New Zealand |
| Judy Pratt | University of Strathclyde, UK |
| Johannes G. Ramaekers | Maastricht University, Netherlands |
| Wim Reidel | Maastricht University, Netherlands |
| Emma SJ Robinson | University of Bristol, UK |
| Craig R. Rush | University of Kentucky, USA |
| Dr Sharon Smith | DevelRx Ltd, UK |
| David Taylor | University of London, UK |
| Joop M.A. van Gerven | CHDR, Leiden, Netherlands |
| Professor Anthony C. Vernon | King's College London, UK |
| Nefize Yalin | King's College London, UK |
| Carlos A. Zarate Jr. | NIMH, Maryland, USA |
| David J Nutt | Imperial College London, UK |
Manuscript submission guidelines can be accessed on Sage Journals.